SciVision Biotech Inc.

TWSE:1786 株式レポート

時価総額:NT$8.7b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

SciVision Biotech 過去の業績

過去 基準チェック /46

SciVision Biotechは、平均年間10.7%の収益成長を遂げていますが、 Medical Equipment業界の収益は、年間 成長しています。収益は、平均年間11.5% 12.9%収益成長率で 成長しています。 SciVision Biotechの自己資本利益率は12.8%であり、純利益率は25%です。

主要情報

10.7%

収益成長率

9.9%

EPS成長率

Medical Equipment 業界の成長11.5%
収益成長率12.9%
株主資本利益率12.8%
ネット・マージン25.0%
前回の決算情報31 Mar 2024

最近の業績更新

Recent updates

SciVision Biotech Inc.'s (TWSE:1786) 27% Price Boost Is Out Of Tune With Earnings

Jun 14
SciVision Biotech Inc.'s (TWSE:1786) 27% Price Boost Is Out Of Tune With Earnings

SciVision Biotech (TWSE:1786) Seems To Use Debt Rather Sparingly

Jun 04
SciVision Biotech (TWSE:1786) Seems To Use Debt Rather Sparingly

Some Shareholders Feeling Restless Over SciVision Biotech Inc.'s (TWSE:1786) P/E Ratio

Apr 01
Some Shareholders Feeling Restless Over SciVision Biotech Inc.'s (TWSE:1786) P/E Ratio

Here's Why SciVision Biotech (TPE:1786) Can Manage Its Debt Responsibly

Apr 20
Here's Why SciVision Biotech (TPE:1786) Can Manage Its Debt Responsibly

SciVision Biotech (TPE:1786) Is Looking To Continue Growing Its Returns On Capital

Apr 02
SciVision Biotech (TPE:1786) Is Looking To Continue Growing Its Returns On Capital

Can You Imagine How SciVision Biotech's (TPE:1786) Shareholders Feel About The 33% Share Price Increase?

Mar 15
Can You Imagine How SciVision Biotech's (TPE:1786) Shareholders Feel About The 33% Share Price Increase?

Read This Before Buying SciVision Biotech Inc. (TPE:1786) For Its Dividend

Feb 25
Read This Before Buying SciVision Biotech Inc. (TPE:1786) For Its Dividend

Could The Market Be Wrong About SciVision Biotech Inc. (TPE:1786) Given Its Attractive Financial Prospects?

Feb 05
Could The Market Be Wrong About SciVision Biotech Inc. (TPE:1786) Given Its Attractive Financial Prospects?

Here's Why SciVision Biotech (TPE:1786) Can Manage Its Debt Responsibly

Jan 18
Here's Why SciVision Biotech (TPE:1786) Can Manage Its Debt Responsibly

Will The ROCE Trend At SciVision Biotech (TPE:1786) Continue?

Jan 01
Will The ROCE Trend At SciVision Biotech (TPE:1786) Continue?

SciVision Biotech (TPE:1786) Shareholders Booked A 80% Gain In The Last Three Years

Dec 14
SciVision Biotech (TPE:1786) Shareholders Booked A 80% Gain In The Last Three Years

Key Things To Consider Before Buying SciVision Biotech Inc. (TPE:1786) For Its Dividend

Nov 25
Key Things To Consider Before Buying SciVision Biotech Inc. (TPE:1786) For Its Dividend

収支内訳

SciVision Biotech の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

TWSE:1786 収益、費用、利益 ( )TWD Millions
日付収益収益G+A経費研究開発費
31 Mar 2478819732356
31 Dec 2371317825953
30 Sep 2367016824545
30 Jun 2362815921744
31 Mar 2357714818449
31 Dec 2255714218552
30 Sep 2253813817457
30 Jun 2250011216163
31 Mar 2249510415065
31 Dec 2150610215466
30 Sep 2149711214666
30 Jun 2149112614664
31 Mar 2146811614462
31 Dec 2046712813760
30 Sep 2046513314152
30 Jun 2044712413548
31 Mar 2044312712843
31 Dec 1943812112843
30 Sep 1941011210849
30 Jun 193801039948
31 Mar 19330818952
31 Dec 18330878848
30 Sep 18314738744
30 Jun 18296588443
31 Mar 18314559140
31 Dec 17258178239
30 Sep 17244217640
30 Jun 17251-287638
31 Mar 17231-286833
31 Dec 16228-266930
30 Sep 16218-377726
30 Jun 16238368624
31 Mar 16250419124
31 Dec 15265559125
30 Sep 15237229531
30 Jun 15197-58434
31 Mar 15181-97837
31 Dec 14158-227837
30 Sep 1417566632
30 Jun 14188266529
31 Mar 14194346326
31 Dec 13201405926
30 Sep 13226635428
30 Jun 13225655030

質の高い収益: 1786は 高品質の収益 を持っています。

利益率の向上: 1786の現在の純利益率 (25%)は、昨年(25.6%)よりも低くなっています。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: 1786の収益は過去 5 年間で年間10.7%増加しました。

成長の加速: 1786の過去 1 年間の収益成長率 ( 33.4% ) は、5 年間の平均 ( 年間10.7%を上回っています。

収益対業界: 1786の過去 1 年間の収益成長率 ( 33.4% ) はMedical Equipment業界-10.2%を上回りました。


株主資本利益率

高いROE: 1786の 自己資本利益率 ( 12.8% ) は 低い とみなされます。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘